Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

Physiological and perceptual responses to exercise according to locus of symptom limitation in COPD.

Tracey L, Lewthwaite H, Abdallah SJ, Murray S, Wilkinson-Maitland CA, Donovan A, Maltais F, O'donnell DE, Bourbeau J, Smith BM, Jensen D; Canadian Respiratory Research Network (CRRN).

Respir Physiol Neurobiol. 2019 Oct 17:103322. doi: 10.1016/j.resp.2019.103322. [Epub ahead of print]

PMID:
31629879
2.

A Rare Complication: Development of an Aspergilloma after Endobronchial Coil Placement in a COPD Patient.

Plante A, Guinde J, Boudreau C, Maltais F, Martel S, Delage A, Fortin M.

Respiration. 2019 Oct 17:1-3. doi: 10.1159/000503363. [Epub ahead of print]

PMID:
31622972
3.

The effects of marijuana smoking on lung function in older people.

Tan WC, Bourbeau J, Aaron SD, Hogg JC, Maltais F, Hernandez P, Marciniuk DD, Chapman KR, To T, FitzGerald JM, Walker BL, Road J, Zheng L, Zhou G, Yau T, Benedetti A, O'Donnell D, Sin DD; CanCOLD Collaborative Research Group.

Eur Respir J. 2019 Sep 19. pii: 1900826. doi: 10.1183/13993003.00826-2019. [Epub ahead of print]

PMID:
31537703
4.

Reliability of quadriceps muscle power and explosive force, and relationship to physical function in people with chronic obstructive pulmonary disease: an observational prospective multicenter study.

Bui KL, Maia N, Saey D, Dechman G, Maltais F, Camp PG, Mathur S.

Physiother Theory Pract. 2019 Sep 19:1-9. doi: 10.1080/09593985.2019.1669233. [Epub ahead of print]

PMID:
31537146
5.

Pulmonary Artery Filling Defects: Beyond Pulmonary Embolism.

Kermelly SB, Côté F, Maltais F.

Am J Respir Crit Care Med. 2019 Sep 13. doi: 10.1164/rccm.201901-0168IM. [Epub ahead of print] No abstract available.

PMID:
31517502
6.

Patient registries for home oxygen research and evaluation.

Lacasse Y, Krishnan JA, Maltais F, Ekström M.

Int J Chron Obstruct Pulmon Dis. 2019 Jun 18;14:1299-1304. doi: 10.2147/COPD.S204391. eCollection 2019.

7.

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD.

Maltais F, Ferguson GT, Feldman GJ, Deslee G, Bourdin A, Fjällbrant H, Siwek-Posłuszna A, Jenkins MA, Martin UJ.

Adv Ther. 2019 Sep;36(9):2434-2449. doi: 10.1007/s12325-019-01015-3. Epub 2019 Jul 2.

PMID:
31267366
8.

Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study.

Shorofsky M, Bourbeau J, Kimoff J, Jen R, Malhotra A, Ayas N, Tan WC, Aaron SD, Sin DD, Road J, Chapman KR, O'Donnell DE, Maltais F, Hernandez P, Walker BL, Marciniuk D, Kaminska M; Canadian Respiratory Research Network and the CanCOLD Collaborative Research group.

Chest. 2019 May 28. pii: S0012-3692(19)31121-3. doi: 10.1016/j.chest.2019.04.132. [Epub ahead of print]

PMID:
31150638
9.

The Relevance of Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: A Review For Clinicians.

Bui KL, Nyberg A, Rabinovich R, Saey D, Maltais F.

Clin Chest Med. 2019 Jun;40(2):367-383. doi: 10.1016/j.ccm.2019.02.013. Review.

PMID:
31078215
10.

Early-onset emphysema in a large French-Canadian family: a genetic investigation.

Bossé Y, Lamontagne M, Gaudreault N, Racine C, Levesque MH, Smith BM, Auger D, Clemenceau A, Paré MÈ, Laviolette L, Tremblay V, Maranda B, Morissette MC, Maltais F.

Lancet Respir Med. 2019 May;7(5):427-436. doi: 10.1016/S2213-2600(19)30056-6. Epub 2019 Apr 15.

PMID:
31000475
11.

Fixed Handheld Dynamometry Provides Reliable and Valid Values for Quadriceps Isometric Strength in People With Chronic Obstructive Pulmonary Disease: A Multicenter Study.

Bui KL, Mathur S, Dechman G, Maltais F, Camp P, Saey D.

Phys Ther. 2019 Sep 1;99(9):1255-1267. doi: 10.1093/ptj/pzz059.

PMID:
30939198
12.

Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstruction.

Boulet LP, Boulay ME, Milot J, Lepage J, Bilodeau L, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 27;14:493-498. doi: 10.2147/COPD.S192003. eCollection 2019.

13.

Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD.

Maltais F, Hamilton A, Voß F, Maleki-Yazdi MR.

Adv Ther. 2019 Apr;36(4):962-968. doi: 10.1007/s12325-019-00911-y. Epub 2019 Mar 6.

PMID:
30843141
14.

Inter-day test-retest reliability and feasibility of isokinetic, isometric, and isotonic measurements to assess quadriceps endurance in people with chronic obstructive pulmonary disease: A multicenter study.

Frykholm E, Géphine S, Saey D, van Hees H, Lemson A, Klijn P, Maltais F, Nyberg A.

Chron Respir Dis. 2019 Jan-Dec;16:1479973118816497. doi: 10.1177/1479973118816497.

15.

Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study.

Paine NJ, Bacon SL, Bourbeau J, Tan WC, Lavoie KL; CanCOLD Study Investigators, Aaron SD, Chapman KR, FitzGerald JM, Hernandez P, Marciniuk DD, Maltais F, O'Donnell DE, Sin D, Walker BL; Canadian Respiratory Research Network and teh CanCOLD Collaborative Research Group.

Respir Med. 2019 Jan;146:1-9. doi: 10.1016/j.rmed.2018.11.006. Epub 2018 Nov 15.

16.

Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD.

Maltais F, Aumann JL, Kirsten AM, Nadreau É, Macesic H, Jin X, Hamilton A, O'Donnell DE.

Eur Respir J. 2019 Mar 28;53(3). pii: 1802049. doi: 10.1183/13993003.02049-2018. Print 2019 Mar.

17.

Effect and feasibility of non-linear periodized resistance training in people with COPD: study protocol for a randomized controlled trial.

Frykholm E, Klijn P, Saey D, van Hees HWH, Stål P, Sandström T, Sörlin A, Maltais F, Nyberg A.

Trials. 2019 Jan 3;20(1):6. doi: 10.1186/s13063-018-3129-y.

18.

Cardiorespiratory and Muscle Oxygenation Responses to Isokinetic Exercise in Chronic Obstructive Pulmonary Disease.

Ribeiro F, Oueslati F, Saey D, Lépine PA, Chambah S, Coats V, Maltais F.

Med Sci Sports Exerc. 2019 May;51(5):841-849. doi: 10.1249/MSS.0000000000001856.

PMID:
30531487
19.

Ectopic adiposity and cardiometabolic health in COPD.

Coats V, Després JP, Alméras N, Martin M, Sin DD, Rabasa-Lhoret R, Larose É, Tan WC, Bourbeau J, Maltais F; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 15;13:3331-3340. doi: 10.2147/COPD.S168963. eCollection 2018.

20.

Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.

Gendron LM, Nyberg A, Saey D, Maltais F, Lacasse Y.

Cochrane Database Syst Rev. 2018 Oct 10;10:CD012290. doi: 10.1002/14651858.CD012290.pub2.

21.

Incorporating telemedicine into the integrated care of the COPD patient a summary of an interdisciplinary workshop held in Stresa, Italy, 7-8 September 2017.

Donner CF, Raskin J, ZuWallack R, Nici L, Ambrosino N, Balbi B, Blackstock F, Casaburi R, Dreher M, Effing T, Goldstein R, Krishnan J, Lareau SC, Make BJ, Maltais F, Meek P, Morgan M, Pépin JL, Rabbito C, Rochester CL, Silverman AR, Singh S, Spruit MA, Vitacca M, Williams L.

Respir Med. 2018 Oct;143:91-102. doi: 10.1016/j.rmed.2018.09.003. Epub 2018 Sep 8. Review.

PMID:
30261999
22.

Automated O2 titration improves exercise capacity in patients with hypercapnic chronic obstructive pulmonary disease: a randomised controlled cross-over trial.

Vivodtzev I, L'Her E, Vottero G, Yankoff C, Tamisier R, Maltais F, Lellouche F, Pépin JL.

Thorax. 2019 Mar;74(3):298-301. doi: 10.1136/thoraxjnl-2018-211967. Epub 2018 Aug 30.

PMID:
30166425
23.

Test-re-test reliability of quadriceps muscle strength measures in people with more severe chronic obstructive pulmonary disease.

Nyberg A, Saey D, Martin M, Maltais F.

J Rehabil Med. 2018 Aug 22;50(8):759-764. doi: 10.2340/16501977-2354.

24.

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, Heijdra YF, van Helvoort H, Garms L, Schneeberger T, Kenn K, Gloeckl R, Langer D.

Thorax. 2018 Oct;73(10):942-950. doi: 10.1136/thoraxjnl-2017-211417. Epub 2018 Jun 18.

PMID:
29914940
25.

Asthma-COPD Overlap Phenotypes and Smoking :Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction.

Boulet LP, Boulay MÈ, Dérival JL, Milot J, Lepage J, Bilodeau L, Maltais F.

COPD. 2018 Apr;15(2):130-138. doi: 10.1080/15412555.2017.1395834. Epub 2018 Apr 23.

PMID:
29683758
26.

Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease.

Troosters T, Maltais F, Leidy N, Lavoie KL, Sedeno M, Janssens W, Garcia-Aymerich J, Erzen D, De Sousa D, Korducki L, Hamilton A, Bourbeau J.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1021-1032. doi: 10.1164/rccm.201706-1288OC.

PMID:
29664681
27.

Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease.

Gauthier A, Bernard S, Bernard E, Simard S, Maltais F, Lacasse Y.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318767724. doi: 10.1177/1479972318767724. Epub 2018 Apr 9.

28.

Exacerbation induces a microbiota shift in sputa of COPD patients.

Jubinville E, Veillette M, Milot J, Maltais F, Comeau AM, Levesque RC, Duchaine C.

PLoS One. 2018 Mar 26;13(3):e0194355. doi: 10.1371/journal.pone.0194355. eCollection 2018.

29.
30.

Home Oxygen in Chronic Obstructive Pulmonary Disease.

Lacasse Y, Tan AM, Maltais F, Krishnan JA.

Am J Respir Crit Care Med. 2018 May 15;197(10):1254-1264. doi: 10.1164/rccm.201802-0382CI. Review.

PMID:
29547003
31.

Ventilatory support or respiratory muscle training as adjuncts to exercise in obese CPAP-treated patients with obstructive sleep apnoea: a randomised controlled trial.

Vivodtzev I, Tamisier R, Croteau M, Borel JC, Grangier A, Wuyam B, Lévy P, Minville C, Sériès F, Maltais F, Pépin JL.

Thorax. 2018 Feb 20. pii: thoraxjnl-2017-211152. doi: 10.1136/thoraxjnl-2017-211152. [Epub ahead of print]

PMID:
29463621
32.

Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.

Maltais F, O'Donnell D, Gáldiz Iturri JB, Kirsten AM, Singh D, Hamilton A, Tetzlaff K, Zhao Y, Casaburi R.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465818755091. doi: 10.1177/1753465818755091.

33.

Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1-2 COPD.

Porszasz J, Carraro N, Cao R, Gore A, Ma S, Jiang T, Maltais F, Ferguson GT, O'Donnell DE, Shaikh A, Rossiter HB, Casaburi R.

Respir Physiol Neurobiol. 2018 May;251:8-15. doi: 10.1016/j.resp.2018.02.006. Epub 2018 Feb 10.

PMID:
29438808
34.

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD.

Singh S, Maltais F, Tombs L, Fahy WA, Vahdati-Bolouri M, Locantore N, Riley JH.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 8;13:203-215. doi: 10.2147/COPD.S145285. eCollection 2018.

35.

Cost-effectiveness of FreeO2 in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in Quebec.

Poder TG, Kouakou CRC, Bouchard PA, Tremblay V, Blais S, Maltais F, Lellouche F.

BMJ Open. 2018 Jan 23;8(1):e018835. doi: 10.1136/bmjopen-2017-018835.

36.

Cardiorespiratory and muscle oxygenation responses to low-load/high-repetition resistance exercises in COPD and healthy controls.

Nyberg A, Saey D, Martin M, Maltais F.

J Appl Physiol (1985). 2018 Apr 1;124(4):877-887. doi: 10.1152/japplphysiol.00447.2017. Epub 2017 Dec 21.

37.

β-Blockers in COPD: A Cohort Study From the TONADO Research Program.

Maltais F, Buhl R, Koch A, Amatto VC, Reid J, Grönke L, Bothner U, Voß F, McGarvey L, Ferguson GT.

Chest. 2018 Jun;153(6):1315-1325. doi: 10.1016/j.chest.2018.01.008. Epub 2018 Jan 31.

38.

Clinical Experience with SERPINA1 DNA Sequencing to Detect Alpha-1 Antitrypsin Deficiency.

Maltais F, Gaudreault N, Racine C, Thériault S, Bossé Y.

Ann Am Thorac Soc. 2018 Feb;15(2):266-268. doi: 10.1513/AnnalsATS.201708-694RL. No abstract available.

PMID:
29182883
39.

Quadriceps muscle fat infiltration is associated with cardiometabolic risk in COPD.

Vivodtzev I, Moncharmont L, Tamisier R, Borel JC, Arbib F, Wuyam B, Lévy P, Maltais F, Ferretti G, Pépin JL.

Clin Physiol Funct Imaging. 2018 Sep;38(5):788-797. doi: 10.1111/cpf.12481. Epub 2017 Nov 3.

PMID:
29105276
40.

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

de Sousa Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD, Benedetti A, Chapman KR, Walker B, Fitzgerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Bourbeau J; CanCOLD Collaborative Research Group and The Canadian Respiratory Research Network.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701154. doi: 10.1183/13993003.01154-2017. Print 2017 Sep. No abstract available.

41.

Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE. No abstract available.

PMID:
28858570
42.

Physical activity patterns and clusters in 1001 patients with COPD.

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA.

Chron Respir Dis. 2017 Aug;14(3):256-269. doi: 10.1177/1479972316687207. Epub 2017 Feb 24.

43.

Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.

O'Donnell DE, Casaburi R, Frith P, Kirsten A, De Sousa D, Hamilton A, Xue W, Maltais F.

Eur Respir J. 2017 Apr 19;49(4). pii: 1601348. doi: 10.1183/13993003.01348-2016. Print 2017 Apr.

44.
45.

Functional Tests in Chronic Obstructive Pulmonary Disease, Part 2: Measurement Properties.

Bui KL, Nyberg A, Maltais F, Saey D.

Ann Am Thorac Soc. 2017 May;14(5):785-794. doi: 10.1513/AnnalsATS.201609-734AS. Review.

PMID:
28244801
46.

Functional Tests in Chronic Obstructive Pulmonary Disease, Part 1: Clinical Relevance and Links to the International Classification of Functioning, Disability, and Health.

Bui KL, Nyberg A, Maltais F, Saey D.

Ann Am Thorac Soc. 2017 May;14(5):778-784. doi: 10.1513/AnnalsATS.201609-733AS. Review.

PMID:
28244799
47.

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.

Martin M, Almeras N, Després JP, Coxson HO, Washko GR, Vivodtzev I, Wouters EF, Rutten E, Williams MC, Murchison JT, MacNee W, Sin DD, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:451-460. doi: 10.2147/COPD.S124750. eCollection 2017.

48.

Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza.

Bandarage UK, Clark MP, Perola E, Gao H, Jacobs MD, Tsai A, Gillespie J, Kennedy JM, Maltais F, Ledeboer MW, Davies I, Gu W, Byrn RA, Nti Addae K, Bennett H, Leeman JR, Jones SM, O'Brien C, Memmott C, Bennani Y, Charifson PS.

ACS Med Chem Lett. 2017 Jan 18;8(2):261-265. doi: 10.1021/acsmedchemlett.6b00487. eCollection 2017 Feb 9.

49.

Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity.

Spina G, Spruit MA, Alison J, Benzo RP, Calverley PMA, Clarenbach CF, Costello RW, Donaire-Gonzalez D, Dürr S, Garcia-Aymerich J, van Gestel AJR, Gramm M, Hernandes NA, Hill K, Hopkinson NS, Jarreta D, Kohler M, Kirsten AM, Leuppi JD, Magnussen H, Maltais F, Man WD, McKeough ZJ, Mesquita R, Miedinger D, Pitta F, Singh SJ, Smeenk FWJM, Tal-Singer R, Vagaggini B, Waschki B, Watz H, Wouters EFM, Zogg S, den Brinker AC.

Thorax. 2017 Aug;72(8):694-701. doi: 10.1136/thoraxjnl-2016-208900. Epub 2017 Jan 12.

50.

Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Lacasse Y, Bernard S, Sériès F, Nguyen VH, Bourbeau J, Aaron S, Maltais F; International Nocturnal Oxygen (INOX) Research Group.

BMC Pulm Med. 2017 Jan 9;17(1):8. doi: 10.1186/s12890-016-0343-9.

Supplemental Content

Loading ...
Support Center